-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ohl2eRkRt+Evk0XwpzIsU/IlVOVcFsYK6Q1HU3ug3PkpHGywydVO6AOStztLojBf wYWBCbYzeTSonp7nAIgizg== 0000919574-99-001056.txt : 19991018 0000919574-99-001056.hdr.sgml : 19991018 ACCESSION NUMBER: 0000919574-99-001056 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19990929 FILED AS OF DATE: 19991007 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TEXAS BIOTECHNOLOGY CORP /DE/ CENTRAL INDEX KEY: 0000887023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133532643 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: SEC FILE NUMBER: 000-20117 FILM NUMBER: 99724718 BUSINESS ADDRESS: STREET 1: DOCTORS CENTER STREET 2: 7000 FANNIN STE 1920 CITY: HOUSTON STATE: TX ZIP: 77030 BUSINESS PHONE: 7137968822 COMPANY DATA: COMPANY CONFORMED NAME: FEINBERG LARRY N CENTRAL INDEX KEY: 0000926475 STANDARD INDUSTRIAL CLASSIFICATION: [] OWNER STATE OF INCORPORATION: NY FILING VALUES: FORM TYPE: 3 BUSINESS ADDRESS: STREET 1: C/O ORACLE PARTNERS L P STREET 2: 712 FIFTH AVENUE 45TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2125741286 MAIL ADDRESS: STREET 1: C/O ORACLE PARTNERS L P STREET 2: 712 FIFTH AVE 45TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 3 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 1. Name and Address of Reporting Person Larry N. Feinberg c/o Oracle Partners, L.P. 712 Fifth Avenue 45th Floor New York, New York 10019 2. Date of Event Requiring Statement (Month/Day/Year) September 29, 1999 3. IRS Reporting Person (Voluntary) 4. Issuer Name and Ticker or Trading Symbol Texas Biotechnology Corporation TXB 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) ( ) Director (X) 10% Owner ( ) Officer (give title below) ( ) Other (specify below) 6. If Amendment, Date of Original (Month/Day/Year) 7. Individual or Joint/Group Filing (Check Applicable Line) (X) Form filed by One Reporting Person ( ) Form filed by More than One Reporting Person Table I -- Non-Derivative Securities Beneficially Owned 1. Title of Security 2. Amount of 3. Ownership 4. Nature of Indirect Securities Form: Beneficial Ownership Beneficially Direct(D) or Owned Indirect(I) Common Stock 3,476,124* (I) General Partner or Investment Manager Table II -- Derivative Securities Beneficially Owned 1.Title of 2.Date Exer- 3.Title and Amount 4.Conver- 5.Ownership 6.Nature of Derivative cisable and of Securities sion or Form of Indirect Security Expiration Underlying Exercise Derivative Beneficial Date Derivative Security Price of Security: Ownership (Month/Day/ --------------- Deri- Direct(D) or Year) Title Amount or vative Indirect (I) --------------- Number of Security Date Expira- Shares Exer- tion cisable Date
EXPLANATION OF RESPONSES: * The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Rule 16a-1(a)(1) or (a)(2) of the Securities Exchange Act of 1934 or for any other purpose. SIGNATURE OF REPORTING PERSON /s/ Larry N. Feinberg _____________________________ Larry N. Feinberg DATE October 7, 1999 2 00751001.BC9
-----END PRIVACY-ENHANCED MESSAGE-----